GLOW Peptide Blend 70mg

Description

GLOW 70mg – Multi-Peptide Research Blend

GLOW 70mg is a research-grade peptide blend supplied for controlled laboratory investigation at 99%+ purity involving peptide signaling, extracellular matrix biology, and molecular pathways associated with connective tissue and dermal research models.

This formulation combines three peptides frequently referenced in scientific literature:

• BPC-157 – 10mg
• TB-500 (Thymosin Beta-4) – 10mg
• GHK-Cu (Copper Peptide) – 50mg

These compounds have appeared in published studies examining molecular pathways including vascular signalling, fibroblast activity, extracellular matrix interactions, and peptide-mediated cellular processes.

GLOW 70mg is supplied exclusively for in-vitro laboratory research and analytical investigation. This product is not approved for human or veterinary use.

What Is GLOW 70mg?

GLOW 70mg is a multi-peptide research formulation designed for laboratory environments investigating peptide interactions within cellular and molecular systems.

Scientific literature referencing these peptides has examined pathways including:

• Extracellular matrix signaling mechanisms
• Collagen-related molecular pathways
• Vascular signalling models
• Fibroblast and connective tissue cellular processes
• Oxidative and inflammatory signaling pathways
• Peptide interaction studies
• Molecular signaling pathway analysis
• Extracellular matrix and collagen-related research models
• Cellular peptide signaling investigations

These pathways remain areas of ongoing experimental research.

Component Research Overview

BPC-157 (10mg)

BPC-157 is a synthetic peptide fragment derived from a protein sequence associated with gastric peptides.

In scientific literature, BPC-157 has been referenced in experimental models examining:

• Peptide signaling within connective tissue models
• Nitric oxide–related molecular pathways
• Vascular signalling pathways
• Inflammatory signaling mechanisms

These references reflect laboratory research contexts only.

TB-500 (Thymosin Beta-4) – 10mg

TB-500 is a synthetic peptide related to the naturally occurring peptide Thymosin Beta-4.

Research literature has examined Thymosin Beta-4–related peptides in studies involving:

• Actin regulation within cellular systems
• Cellular migration signaling models
• Vascular signalling pathways
• Peptide activity within musculoskeletal research models

These topics remain subjects of ongoing laboratory investigation.

GHK-Cu (Copper Peptide) – 50mg

GHK-Cu is a copper-binding peptide that occurs naturally in human plasma and has been widely examined in biochemical and molecular research.

Published studies referencing GHK-Cu have explored:

• Copper-peptide interactions within biological systems
• Collagen-related signaling pathways
• Gene expression associated with extracellular matrix biology
• Oxidative and inflammatory signaling models

The concentration of GHK-Cu within GLOW 70mg may allow researchers to investigate copper-peptide pathways within controlled laboratory settings.

GLOW 70mg – Research Supply Specifications

• Multi-peptide research blend
• Total peptide content: 70mg lyophilized powder
• Analytical purity standard: 99%+
• Third-party laboratory testing for identity and purity
• Manufactured under controlled quality standards
• Canada-based fulfillment
• Batch-level quality control procedures

Purity & Quality Assurance

ExoLabz supplies research peptides manufactured to high analytical standards. ExoLabz products undergo independent third-party testing to confirm peptide identity and purity. Results are published on this site.

Researchers may conduct additional analytical verification as required for laboratory use. If validated testing confirms a verified purity discrepancy, ExoLabz provides refund and testing reimbursement in accordance with company policy.

Important Legal Notice

For Research Purposes Only

GLOW 70mg is supplied strictly for laboratory research and analytical use.

This compound is not intended for human consumption, veterinary use, clinical research involving human subjects, therapeutic use, or diagnostic applications.

This product has not been evaluated or approved by Health Canada, the U.S. Food and Drug Administration (FDA), or any other regulatory authority.

By purchasing this product, the buyer acknowledges that the material will be handled only by qualified professionals and used solely for lawful laboratory research purposes.

Compound identity and specification

GLOW 70mg is a blend, so identity is given per component. Each formula, mass and registry number below is verified against PubChem and can be looked up directly.

Analytical note — BPC-157. A pentadecapeptide with three consecutive prolines. Proline-rich sequences broaden on reverse-phase HPLC because the bond preceding each proline interconverts between cis and trans conformations slowly relative to the run, so a broad or shouldered peak is a property of the molecule rather than evidence of a second substance.

Analytical note — TB-500. TB-500 is the short acetylated fragment, not full-length thymosin beta-4, which is a 43-residue protein of about 4,963 g/mol. The two are routinely conflated. A mass near 889 confirms the fragment; a mass near 4,963 would be a different product entirely.

Analytical note — GHK-Cu. This is a metal complex, not a plain peptide, and it behaves accordingly: the copper can dissociate on-column under acidic reverse-phase conditions, so an analysis may report the free tripeptide rather than the complex. Two CAS numbers circulate because one belongs to the peptide and one to the complex; both are given above rather than merged.

Identity references The molecular formula, molecular mass and CAS registry number above are taken from the PubChem record linked in the table, not from a supplier datasheet, so every figure can be checked against an independent source in one click. Sequences are given as reported in the peptide literature, in the one-letter or three-letter convention as appropriate, with any non-standard residue named in full. Where a compound exists in more than one form — a free peptide and a metal complex, a fragment and its parent protein, a modified and an unmodified analog — the form supplied is the one identified here, and the mass on the certificate of analysis is what distinguishes it.

Research Literature

Peer-reviewed studies involving this compound and its class. All findings listed are from in vitro, cell culture or animal models and are provided for scientific reference only. This product is supplied for laboratory research and is not approved for human consumption, clinical, or veterinary use.

• Chang CH, et al. J Appl Physiol. 2011;110(3):774-780. In rat Achilles tendon explant culture and isolated tendon fibroblasts, measured explant outgrowth, fibroblast survival under oxidative stress, migration, and FAK/paxillin phosphorylation. Source · PMID 21030672
• Hsieh MJ, et al. J Mol Med (Berl). 2017;95(3):323-333. In chick chorioallantoic membrane assay, a rat hind-limb ischaemia model and human endothelial cell culture, measured vessel density, endothelial tube formation and VEGFR2-Akt-eNOS phosphorylation. Source · PMID 27847966
• Chang CH, et al. Molecules. 2014;19(11):19066-19077. In primary tendon fibroblasts from Sprague-Dawley rat Achilles tendon, measured growth hormone receptor mRNA and protein levels, PCNA expression and JAK2 phosphorylation. Source · PMID 25415472
• Bock-Marquette I, et al. Nature. 2004;432(7016):466-472. In embryonic mouse cardiomyocyte and endothelial culture and a mouse coronary artery ligation model, measured cell migration, myocyte survival and ILK/Akt kinase activity. Source · PMID 15565145
• Malinda KM, et al. FASEB J. 1997;11(6):474-481. In human umbilical vein endothelial cell (HUVEC) culture, measured directional chemotactic migration in Boyden-chamber assays. Source · PMID 9194528
• Philp D, et al. FASEB J. 2003;17(14):2103-2105. In HUVEC culture and chick aortic arch explants, measured migration, adhesion and vessel sprouting elicited by the LKKTETQ actin-binding motif at approximately 50 nM. Source · PMID 14500546
• Maquart FX, et al. FEBS Lett. 1988;238(2):343-346. In cultured fibroblasts, measured collagen synthesis rates in response to the GHK-Cu2+ complex. Source · PMID 3169264
• Simeon A, et al. Life Sci. 2000;67(18):2257-2265. In fibroblast culture, measured matrix metalloproteinase-2 expression and activity by zymography after GHK-Cu2+ exposure. Source · PMID 11045606
• Simeon A, et al. J Invest Dermatol. 2000;115(6):962-968. In rat dermal fibroblast culture and a rodent in vivo model, measured glycosaminoglycan levels and decorin and biglycan mRNA. Source · PMID 11121126

Literature notes: The published base for this compound is small and concentrated in a limited number of research groups, with little independent replication of in vivo findings. Published work concerns full-length thymosin beta-4 or its LKKTETQ actin-binding fragment. Equivalence between those and material marketed as TB-500 is not established in the literature.

The third-party report for this material is published on this page, and every certificate we hold is collected on the certificates of analysis page.

Related Research Compounds

Browse more compounds in Multi-Peptide Blends, or view the full research peptide catalogue.

• KLOW 80mg